584 filings
8-K
ENZ
Enzo Biochem, Inc.
13 Mar 24
Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business Update
4:31pm
10-Q
2024 Q2
ENZ
Enzo Biochem, Inc.
Quarterly report
13 Mar 24
4:25pm
8-K
ENZ
Enzo Biochem, Inc.
27 Feb 24
Departure of Directors or Certain Officers
4:05pm
8-K
ENZ
Enzo Biochem, Inc.
1 Feb 24
Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments
8:33am
DEFR14A
ENZ
Enzo Biochem, Inc.
21 Dec 23
Revised proxy
4:48pm
ARS
fskekffl zqq
21 Dec 23
Annual report to shareholders
4:15pm
NT 10-K
lnn5xb ue5fmqeqmw
30 Oct 23
Notice of late annual filing
6:19pm
8-K
lu9h323fyhnllm heb
30 Oct 23
Departure of Directors or Certain Officers
4:50pm
8-K
ntv95t0v t12ubj7e8q
6 Sep 23
Enzo Biochem Announces Departure of Hamid Erfanian and Appointment of Kara Cannon as Interim CEO
6:12pm
8-K/A
8lnd mt4m7h03kkqee
28 Jul 23
Financial Statements and Exhibits
5:19pm
8-K
h2lge dry4mqv8yl9mh
24 Jul 23
Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp
4:32pm
EFFECT
lsaeph1efrv12df
19 Jul 23
Notice of effectiveness
12:15am
424B3
y9kf1r2xi
18 Jul 23
Prospectus supplement
9:42pm
CORRESP
7bmvd810fk1iup54r
18 Jul 23
Correspondence with SEC
12:00am
CORRESP
ekhg8ix9n 3zhzc
18 Jul 23
Correspondence with SEC
12:00am
8-K
xku2aw
17 Jul 23
Other Events
1:38pm